ArticleMolecular imaging and biology2025

Peptide Receptor Radionuclide Therapy with Lu-177-DOTATATE and Monitoring with Somatostatin Receptor PET/CT in Patients with Advanced Differentiated Thyroid Carcinoma.

Sophie Carina Kunte et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.